CY1775A - Anhydrous crystalline sodium salt of 5-chloro-3- (2-thenoyl)-2- oxindole-1-carboxamide - Google Patents

Anhydrous crystalline sodium salt of 5-chloro-3- (2-thenoyl)-2- oxindole-1-carboxamide

Info

Publication number
CY1775A
CY1775A CY177596A CY177596A CY1775A CY 1775 A CY1775 A CY 1775A CY 177596 A CY177596 A CY 177596A CY 177596 A CY177596 A CY 177596A CY 1775 A CY1775 A CY 1775A
Authority
CY
Cyprus
Prior art keywords
thenoyl
oxindole
carboxamide
chloro
sodium salt
Prior art date
Application number
CY177596A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CY1775A publication Critical patent/CY1775A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY177596A 1987-02-02 1996-04-05 Anhydrous crystalline sodium salt of 5-chloro-3- (2-thenoyl)-2- oxindole-1-carboxamide CY1775A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (1)

Publication Number Publication Date
CY1775A true CY1775A (en) 1996-04-05

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
CY177596A CY1775A (en) 1987-02-02 1996-04-05 Anhydrous crystalline sodium salt of 5-chloro-3- (2-thenoyl)-2- oxindole-1-carboxamide

Country Status (42)

Country Link
US (1) US5036099A (es)
EP (1) EP0277738B1 (es)
JP (1) JPS63201184A (es)
KR (1) KR900001422B1 (es)
CN (1) CN1022324C (es)
AP (1) AP52A (es)
AR (1) AR243182A1 (es)
AT (1) ATE73800T1 (es)
AU (1) AU587736B2 (es)
BG (1) BG51042A3 (es)
CA (1) CA1335590C (es)
CS (2) CS265250B2 (es)
CY (1) CY1775A (es)
DD (1) DD267490A5 (es)
DE (1) DE3869149D1 (es)
DK (1) DK44888A (es)
EC (1) ECSP941082A (es)
ES (1) ES2032955T3 (es)
FI (1) FI89598C (es)
GR (1) GR3004200T3 (es)
HK (1) HK132695A (es)
IE (1) IE60000B1 (es)
IL (1) IL85277A (es)
IN (1) IN171799B (es)
IS (1) IS1533B (es)
LV (1) LV10252B (es)
MA (1) MA21171A1 (es)
MY (1) MY102737A (es)
NO (1) NO170581C (es)
NZ (1) NZ223373A (es)
OA (1) OA08710A (es)
PH (1) PH26545A (es)
PL (1) PL149550B1 (es)
PT (1) PT86675B (es)
RO (1) RO105052B1 (es)
RU (1) RU2011381C1 (es)
SG (1) SG27994G (es)
SI (1) SI8810183A8 (es)
UA (1) UA25898A1 (es)
WO (1) WO1988005656A1 (es)
YU (1) YU46766B (es)
ZA (1) ZA88679B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
SK590689A3 (en) * 1988-10-18 1996-03-06 Pfizer 3-aryl-2-oxindole-1-carboxamides and method of their preparation
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
KR20200085285A (ko) 2017-11-02 2020-07-14 애커러트 메디컬 테라퓨틱스 엘티디. 필터가 내장된 색전술용 카테터

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
ATE63543T1 (de) * 1984-02-07 1991-06-15 Pfizer 2-oxindolzwischenprodukte.
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3579716D1 (de) * 1984-03-19 1990-10-25 Pfizer Verfahren zur herstellung von 2-oxindole-1-carboxamiden und deren zwischenprodukte.
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
AP8800081A0 (en) 1987-11-01
FI893647A0 (fi) 1989-08-01
JPH0576945B2 (es) 1993-10-25
IE880269L (en) 1988-08-02
CS354191A3 (en) 1992-04-15
ZA88679B (en) 1989-09-27
AR243182A1 (es) 1993-07-30
IS3309A7 (is) 1988-08-03
UA25898A1 (uk) 1999-02-26
CA1335590C (en) 1995-05-16
PH26545A (en) 1992-08-19
CS64888A2 (en) 1988-08-16
AU1116088A (en) 1988-08-04
IL85277A (en) 1994-02-27
NO170581B (no) 1992-07-27
MY102737A (en) 1992-09-30
SG27994G (en) 1994-10-14
AP52A (en) 1989-09-16
IS1533B (is) 1994-01-28
EP0277738B1 (en) 1992-03-18
CN1022324C (zh) 1993-10-06
RO105052B1 (en) 1994-12-01
BG51042A3 (en) 1993-01-15
YU18388A (en) 1989-10-31
NO884329L (no) 1988-09-29
KR880009961A (ko) 1988-10-06
YU46766B (sh) 1994-05-10
PL149550B1 (en) 1990-02-28
DK44888A (da) 1988-08-03
DD267490A5 (de) 1989-05-03
AU587736B2 (en) 1989-08-24
MA21171A1 (fr) 1988-10-01
IN171799B (es) 1993-01-09
IL85277A0 (en) 1988-07-31
KR900001422B1 (ko) 1990-03-09
PT86675A (pt) 1988-03-01
PT86675B (pt) 1992-07-31
SI8810183A8 (sl) 1996-08-31
OA08710A (fr) 1989-03-31
DK44888D0 (da) 1988-01-29
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
GR3004200T3 (es) 1993-03-31
ES2032955T3 (es) 1996-07-16
FI89598B (fi) 1993-07-15
PL270415A1 (en) 1988-12-08
CN88100555A (zh) 1988-08-17
EP0277738A1 (en) 1988-08-10
IE60000B1 (en) 1994-05-18
ECSP941082A (es) 1994-12-15
NZ223373A (en) 1989-06-28
HK132695A (en) 1995-09-01
NO884329D0 (no) 1988-09-29
ATE73800T1 (de) 1992-04-15
RU2011381C1 (ru) 1994-04-30
FI89598C (fi) 1993-10-25
LV10252A (lv) 1994-10-20
DE3869149D1 (de) 1992-04-23
CS265250B2 (en) 1989-10-13
US5036099A (en) 1991-07-30
NO170581C (no) 1992-11-04
WO1988005656A1 (en) 1988-08-11

Similar Documents

Publication Publication Date Title
CY1775A (en) Anhydrous crystalline sodium salt of 5-chloro-3- (2-thenoyl)-2- oxindole-1-carboxamide
GB8715064D0 (en) Crystalline oral cephalosporin hydrate
DE3474023D1 (en) Crystalline amoxycillin salt
GB8721294D0 (en) Salts of organogermanium compounds
GB8829136D0 (en) Tromethamine salt of 1-methyl-beta-oxo-alpha-(phenylcarbamoyl)-2-pyrrolepropionitrile
ZA885263B (en) Crystalline monohydrate of sodium n-(1h-tetrazol-5-yl)-1-phenoxy-4h-quinolizin-4-one-3-carboxamide
GB8825422D0 (en) Crystallisation of sodium oxalates
IL78424A0 (en) Crystalline anhydrous sodium 19-deoxyaglycone dianemycin
EG18479A (en) Process for preparing anhydrous crystalling sodium salt of 5-chloro-3-(2-thenoyl)-2 oxindole-1 carboxamide
CS809187A1 (en) Sodium salt of carboxymethyl-/1-6/-beta-d-gluco-/1-3-beta-d-glucan
AU2014488A (en) Crystalline monohydrate of sodium n-(1h-tetrazol-5-yl)-1-phenoxy-4h-quinolizin-4-one-3- carboxamide
PL285899A1 (en) Method of obtaining sodium salt of penicillanic acid 1,1-dioxide
IE882878L (en) Production of anhydrous sodium cyanide crystals
LV5721A4 (lv) 5-Hlor-3-(2-tenoil)-2-oksindola-1-karboksamida bezudens kristaliska natrija sals
CS150688A1 (en) Process for preparing sodium salt of 1-amino-4-bromantraquinon-2-sulphonic acid
PL296536A1 (en) Method of obtaining crystalline sodium salt of cephoperazone
JPS6428216A (en) Purification of barium salt
BG47572A1 (en) Method for preparing of sodium salt of o- formylcephamandol
GB8721567D0 (en) Salts of cephem compounds
GB8725051D0 (en) Salts of cephem compounds
GB8718905D0 (en) Salts of new cephem compounds
GB8304662D0 (en) Sodium salt of hydroxypyrazine
CS350890A3 (en) Sodium salt of (4--0-methyl-alpha-d-glucurono)-beta-d-xylanurea
AU2452888A (en) Crystallisation of sodium oxalates
IE870518L (en) Purification of barium salt